Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 9;9(2):231.
doi: 10.3390/jof9020231.

Antifungal and Antibiofilm Activity of Riparin III against Dermatophytes

Affiliations

Antifungal and Antibiofilm Activity of Riparin III against Dermatophytes

Emanuel Pereira Silva et al. J Fungi (Basel). .

Abstract

The ability of dermatophytes to develop biofilms is possibly involved in therapeutic failure because biofilms impair drug effectiveness in the infected tissues. Research to find new drugs with antibiofilm activity against dermatophytes is crucial. In this way, riparins, a class of alkaloids that contain an amide group, are promising antifungal compounds. In this study, we evaluated the antifungal and antibiofilm activity of riparin III (RIP3) against Trichophyton rubrum, Microsporum canis, and Nannizzia gypsea strains. We used ciclopirox (CPX) as a positive control. The effects of RIP3 on fungal growth were evaluated by the microdilution technique. The quantification of the biofilm biomass in vitro was assessed by crystal violet, and the biofilm viability was assessed by quantifying the CFU number. The ex vivo model was performed on human nail fragments, which were evaluated by visualization under light microscopy and by quantifying the CFU number (viability). Finally, we evaluated whether RIP3 inhibits sulfite production in T. rubrum. RIP3 inhibited the growth of T. rubrum and M. canis from 128 mg/L and N. gypsea from 256 mg/L. The results showed that RIP3 is a fungicide. Regarding antibiofilm activity, RIP3 inhibited biofilm formation and viability in vitro and ex vivo. Moreover, RIP3 inhibited the secretion of sulfite significantly and was more potent than CPX. In conclusion, the results indicate that RIP3 is a promising antifungal agent against biofilms of dermatophytes and might inhibit sulfite secretion, one relevant virulence factor.

Keywords: alkamides; antifungal; dermatophytes; ex vivo; fungicide; riparin; sulfites.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of riparins I, II, and III (RIP3).
Figure 2
Figure 2
Effect of RIP3 on the biofilm biomass of dermatophytes expressed as absorbance of the crystal violet staining. The results are the means ± SD from three independent experiments. Significant difference (p < 0.05) when compared to drug-free growth control (a) and to CPX at the respective MIC value (b). OD, optical density; MIC, minimal inhibitory concentration; RIP3, riparin III; CPX, ciclopirox.
Figure 3
Figure 3
Effect of RIP3 on the viability of in vitro biofilms of dermatophytes determined by quantifying the number of colony-forming units (CFU). The results are the means ± SD from three independent experiments. Significant difference (p < 0.05) when compared to drug-free growth control (a) and to CPX at the respective MIC value (b). OD, optical density; MIC, minimal inhibitory concentration; RIP3, riparin III; CPX, ciclopirox.
Figure 4
Figure 4
Effect of RIP3 on the viability of ex vivo biofilms (nail fragments) of dermatophytes determined by quantifying the number of colony-forming units (CFU). The results are the means ± SD from three independent experiments. Significant difference (p < 0.05) when compared to drug-free growth control (a) and CPX at the respective MIC value (b). OD, optical density; MIC, minimal inhibitory concentration; RIP3, riparin III; CPX, ciclopirox.

Similar articles

Cited by

References

    1. Gnat S., Nowakiewicz A., Zięba P. Taxonomy of Dermatophytes—The Classification Systems May Change but the Identification Problems Remain the Same. Postępy Mikrobiol.—Adv. Microbiol. 2019;58:49–58. doi: 10.21307/PM-2019.58.1.049. - DOI
    1. Zhan P., Liu W. The Changing Face of Dermatophytic Infections Worldwide. Mycopathologia. 2017;182:77–86. doi: 10.1007/s11046-016-0082-8. - DOI - PubMed
    1. De Oliveira Pereira F., Gomes S.M., Da Silva S.L., De Castro Teixeira A.P., Lima I.O. The Prevalence of Dermatophytoses in Brazil: A Systematic Review. J. Med. Microbiol. 2021;70:001321. doi: 10.1099/jmm.0.001321. - DOI - PubMed
    1. Huang C., Peng Y., Zhang Y., Li R., Wan Z., Wang X. Deep Dermatophytosis Caused by Trichophyton rubrum. Lancet Infect. Dis. 2019;19:1380. doi: 10.1016/S1473-3099(19)30551-1. - DOI - PubMed
    1. Rouzaud C., Lanternier F., Puel A. Primary Immunodeficiencies and Dermatophytosis. In: Springer C., editor. Immunogenetics of Fungal Diseases. Springer International Publishing; Berlin/Heidelberg, Germany: 2017. pp. 121–133.

LinkOut - more resources